June 15, 2020 / 5:56 AM / a month ago

BRIEF-Zealand Pharma Presents Elaborated Results For Dasiglucagon Rescue Therapy

June 15 (Reuters) - Zealand Pharma:

* SAID ON SUNDAY HAS PRESENTED ELABORATED RESULTS FROM TWO PHASE 3 CLINICAL STUDIES WITH DASIGLUCAGON AS TREATMENT FOR SEVERE HYPOGLYCEMIA AS WELL AS ONE PRECLINICAL PK/PD STUDY

* PRIMARY AND ALL SECONDARY ENDPOINTS WERE MET IN BOTH PHASE 3 STUDIES

* DASIGLUCAGON SHOWED ADVERSE EVENTS CONSISTENT WITH KNOWN CLASS EFFECTS; NO SERIOUS OR SEVERE ADVERSE EVENTS WERE REPORTED

Source text for Eikon:

Further company coverage: (Gdansk Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below